|
In order to help WHO member countries towards integrating their public health programmes with pharmacovigilance (PV), the Indian Pharmacopoeia Commission (IPC) Ghaziabad will conduct PV training for 30 participants of WHO member countries from Africa, Europe and South East Asia.
The training programme which will be conducted at IPC is done in collaboration with Uppsala Monitoring Centre (UMC), Sweden between March 4 and March 14, 2019.
The training which is meant for learners and beginners will throw light on the basic aspects of PV with focus on public health and patient safety. This initiative is very much relevant as IPC is currently serving as the 8th WHO collaborative centre for PV in public health and regulatory services from India.
PV is of utmost significance for the WHO member countries as many of the medicines used in public health programmes are new and have safety concerns associated with them.
The training would also talk about the collaboration with WHO members on the establishment and training of a PV field force to actively assemble adverse drug reaction (ADR) information from the programme treatment centres.
As a part of its initiatives in PV, IPC under the union health ministry has also chalked out a plan to support South East Asia Regulatory Network (SEARN) nation countries towards integrating their public health programmes with PV activities towards drug safety.
Uppsala Monitoring Centre (UMC) was the first WHO Collaborating Centre to be established for PV when, in 1978, the scientific and technical responsibility of the WHO programme for international drug monitoring was transferred to Sweden.
IPC has also been assigned to update information on ADR data that is being reported in India from across all its centres through Vigiflow software to the UMC in Sweden, which is WHO's collaborating centre for international drug monitoring.
Central Drugs Standard Control Authority (CDSCO) which is also a member of South East Asian Regional Network (SEARN) is also in the process of serving the PV needs of member countries like Bangladesh, Bhutan, Korea, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand and Timor to build capacity and enable respective nations to fulfill their mandate of safeguarding public health.
CDSCO had initiated a nation-wide Pharmacovigilance Programme of India (PvPI) in July 2010 with Ghaziabad based IPC as the national co-ordinating centre (NCC).
|